Brought to you by 
Gen-Probe to buy Prodesse for $60mm plus earn-outs
08 Oct 2009
Executive Summary
Adding to its portfolio of nucleic acid diagnostics, Gen-Probe is acquiring private molecular diagnostics firm Prodesse for $60mm in cash, plus up to $25mm if financial and regulatory milestones are met in 2010 and 2011.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Laboratory Testing Services
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gen-Probe to buy Prodesse for $60mm plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice